Which imaging modality uses a radiopharmaceutical to evaluate bone metabolism?

Which imaging modality uses a radiopharmaceutical to evaluate bone metabolism?

• A. MRI.
• B. Bone scan.
• C. CT.
• D. Ultrasound.

Answer: (B)

Evaluating bone metabolism with imaging relies on detecting metabolic activity in bone using a radiotracer. A bone scan uses a radiopharmaceutical, typically technetium-99m–labeled diphosphonates, injected into the bloodstream. These compounds localize to bone in proportion to blood flow and osteoblastic (bone-forming) activity. A gamma camera then captures the emitted radiation to create images where areas of increased uptake indicate higher metabolic activity, such as healing fractures, infection, tumors, or inflammatory processes. Other modalities don’t use a radiopharmaceutical to measure metabolism: MRI relies on magnetic fields and sometimes contrast agents to image tissue properties and anatomy; CT uses X-ray attenuation for structural detail; ultrasound uses sound waves to visualize soft tissues and surfaces.

Evaluating bone metabolism with imaging relies on detecting metabolic activity in bone using a radiotracer. A bone scan uses a radiopharmaceutical, typically technetium-99m–labeled diphosphonates, injected into the bloodstream. These compounds localize to bone in proportion to blood flow and osteoblastic (bone-forming) activity. A gamma camera then captures the emitted radiation to create images where areas of increased uptake indicate higher metabolic activity, such as healing fractures, infection, tumors, or inflammatory processes.

Other modalities don’t use a radiopharmaceutical to measure metabolism: MRI relies on magnetic fields and sometimes contrast agents to image tissue properties and anatomy; CT uses X-ray attenuation for structural detail; ultrasound uses sound waves to visualize soft tissues and surfaces.